PENNYBUSTER'S PENNY BUSTIN PLAYS!!

[Pennybuster]

$LIFE One stock with some decent insider buying is biotherapeutics player aTyr Pharma $LIFE which engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. Insiders are buying this stock into massive weakness, since shares have plunged by 65% over the last six months.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks with serious upside potential in the next 12-months. Learn more.


aTyr Pharma has a market cap of $92.3 million and an enterprise value of -$11.3 million. This stock trades at a fair valuation, with a price-to-book of 0.71. Its estimated growth rate for this year is 2.6%, and for next year it's pegged at -11.5%. This is a cash-rich company, since the total cash position on its balance sheet is $108.80 million and its total debt is $5.95 million.

Must Read: These 5 Energy Stocks Are in Breakout Mode

A director just bought 85,000 shares, or about $273,000 worth of stock at $3.22 per share. That same director also just bought 32,659 shares, or about $116,000 worth of stock at $3.45 per share.

From a technical perspective, aTyr Pharma is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been uptrending strong over the last few trading sessions, with shares moving higher off its new 52-week low of $3.03 a share to its intraday high on Wednesday of $4.02 a share. During that uptrend, shares of aTyr Pharma has been making mostly higher lows and higher highs, which is bullish technical price action. This stock has also seen an extreme spike in its upside volume over these last few trading sessions, and it's now quickly moving within range of triggering a near-term breakout trade.

If you're bullish on aTyr Pharma, then I would look for long-biased trades as long as this stock is trending above some its new 52-week low of $3.03 a share and then once it breaks out above some near-term overhead resistance at $4.08 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 325,463 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 20-day moving average of $4.39 a share to its 50-day moving average of $4.58 a share, or even $5 to $5.50 a share.

http://www.thestreet.com/story/13529550/2/5-stocks-with-big-insider-buying.html